Principles of Pharmacovigilance

Egis Pharmaceuticals PLC and EGIS Polska Sp. z o.o. is committed to the safe use of drugs. Therefore we pay special attention to the collection and evaluation of the adverse events and quality complaints experienced in relation to the use of our products.

Our aim is to provide patients, physicians and pharmacists who use our products with information, which reflects the current views of medical science and which contains all the data and knowledge necessary for the safe use of our products in order to facilitate the patients’ recovery and to minimize the risks of side effects.

To reach this goal we need the cooperation of patients, practicing physicians and pharmacists in reporting suspected adverse drug reactions noticed in their professional practice. It is our firm belief that the safety of medicinal treatment is our common interest.

Please report any adverse events possibly related to the products of Egis Pharmaceuticals PLC, as well as medicines being products of companies covered by our therapy safety supervision system: Egis Polska, Proterapia, Celltrion, Colep using the on-line form:

Link: Formularz Zgłoś Działanie Niepożądane Leku >>

EGIS Polska Sp. z o.o.
Telefon:  +48 22 417 92 00
Telefaks:  +48 22 417 92 92
Adres: ul. Komitetu Obrony Robotników 45D, 02-146 Warszawa

WarningYour browser is out of date. Please, use an updated version! Chrome || Firefox